CD49f Is an Efficient Marker of Monolayer- and Spheroid Colony-Forming Cells of the Benign and Malignant Human Prostate

作者: Hidekazu Yamamoto , John R. Masters , Prokar Dasgupta , Ashish Chandra , Rick Popert

DOI: 10.1371/JOURNAL.PONE.0046979

关键词:

摘要: Stem cells may play a role in the development and maintenance of proliferative diseases prostate such as cancer benign prostatic hyperplasia. Cell membrane protein markers, CD49f, CD133 CD44, have been shown to identify putative stem cells, but lack consensus exists with regards most efficient marker(s) for stem-like cell identification. This study aimed determine whether previously reported markers had equal capacity select monolayer spheroid colony-forming (CFCs), which were used surrogate readouts characterize expression CD44 by flow cytometry immunohistochemistry. In CD49f+, CD44+, CD133+ represented 5.6±3.1%, 28.2±4.1% 0.10±0.06% total cells. Both monolayer- spheroid-CFCs existed at frequency approximately 0.5% subpopulations differed significantly their ability CFCs. The highest recovery CFCs was achieved CD49f+ selection (98%), whereas CD44+ or led poor CFC-recovery (17% 3%, respectively). For first time, we show highly from advanced not selection. Furthermore, (AC133 clone) could be detected either immunohistochemistry cytometry. We conclude that described optimal malignant prostate.

参考文章(55)
Sheri Miraglia, Wayne Godfrey, Amy H. Yin, Kristin Atkins, Roger Warnke, Jeannine T. Holden, Robert A. Bray, Edmund K. Waller, David W. Buck, A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. ,vol. 90, pp. 5013- 5021 ,(1997) , 10.1182/BLOOD.V90.12.5013
H Ema, T Suda, Y Miura, H Nakauchi, Colony formation of clone-sorted human hematopoietic progenitors Blood. ,vol. 75, pp. 1941- 1946 ,(1990) , 10.1182/BLOOD.V75.10.1941.1941
B. L. Dalkin, A. E. Cress, K. S. Affinito, V. Clark, L. Manriquez, R. B. Nagle, J. D. Knox, Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. American Journal of Pathology. ,vol. 145, pp. 167- 174 ,(1994)
K. Miller, C. Börgermann, J. Thüroff, P. Albers, M. Wirth, [Therapeutic options for hormone-refractory prostate cancer]. Urologe A. ,vol. 45, pp. 580- 585 ,(2006) , 10.1007/S00120-006-1048-0
Alvin Y. Liu, Differential Expression of Cell Surface Molecules in Prostate Cancer Cells Cancer Research. ,vol. 60, pp. 3429- 3434 ,(2000)
Norman J. Maitland, Anne T. Collins, David E. Neal, Fouad K. Habib, Identification and isolation of human prostate epithelial stem cells based on α2β1-integrin expression Journal of Cell Science. ,vol. 114, pp. 3865- 3872 ,(2001) , 10.1242/JCS.114.21.3865
Toshiro Sato, Robert G. Vries, Hugo J. Snippert, Marc van de Wetering, Nick Barker, Daniel E. Stange, Johan H. van Es, Arie Abo, Pekka Kujala, Peter J. Peters, Hans Clevers, Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche Nature. ,vol. 459, pp. 262- 265 ,(2009) , 10.1038/NATURE07935
Vinagolu K. Rajasekhar, Lorenz Studer, William Gerald, Nicholas D. Socci, Howard I. Scher, Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling. Nature Communications. ,vol. 2, pp. 162- 162 ,(2011) , 10.1038/NCOMMS1159
Isla P. Garraway, Wenyi Sun, Chau P. Tran, Sven Perner, Bao Zhang, Andrew S. Goldstein, Scott A. Hahm, Maahum Haider, Christian S. Head, Robert E. Reiter, Mark A. Rubin, Owen N. Witte, Human prostate sphere-forming cells represent a subset of basal epithelial cells capable of glandular regeneration in vivo. The Prostate. ,vol. 70, pp. 491- 501 ,(2010) , 10.1002/PROS.21083
Naotsugu Haraguchi, Masahisa Ohkuma, Hiroyuki Sakashita, Shinji Matsuzaki, Fumiaki Tanaka, Koshi Mimori, Yukio Kamohara, Hiroshi Inoue, Masaki Mori, CD133+CD44+ population efficiently enriches colon cancer initiating cells Annals of Surgical Oncology. ,vol. 15, pp. 2927- 2933 ,(2008) , 10.1245/S10434-008-0074-0